The Current Ratio as of November 2024 (TTM) for Surrozen, Inc. (SRZN) is 7.40

According to Surrozen, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.40. This represents a change of 17.02% compared to the average of 6.32 of the last 4 quarters.

Surrozen, Inc. (SRZN) Historical Current Ratio (quarterly & annually)

How has SRZN Current Ratio performed in the past?

The mean historical Current Ratio of Surrozen, Inc. over the last ten years is 7.26. The current 7.40 Current Ratio has changed 10.09% with respect to the historical average. Over the past ten years (40 quarters), SRZN's Current Ratio was at its highest in in the March 2022 quarter at 11.79. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Surrozen, Inc. (SRZN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Surrozen, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Surrozen, Inc. (SRZN) Average Current Ratio

How has SRZN Current Ratio performed in the past?

The current Current Ratio of Surrozen, Inc. (SRZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Surrozen, Inc. (SRZN) Current Ratio vs. Peers

How is SRZN’s Current Ratio compared to its peers?

Surrozen, Inc.’s Current Ratio is greater than Bolt Biotherapeutics, Inc. (3.16), less than Larimar Therapeutics, Inc. (13.10), less than Keros Therapeutics, Inc. (19.03), less than Kezar Life Sciences, Inc. (7.65), greater than Processa Pharmaceuticals, Inc. (3.97), greater than NexImmune, Inc. (0.66), greater than Evelo Biosciences, Inc. (0.48), greater than Tempest Therapeutics, Inc. (1.69), less than Replimune Group, Inc. (10.11), greater than Nuvectis Pharma, Inc. (2.74), greater than Lyra Therapeutics, Inc. (3.64), less than Kronos Bio, Inc. (8.32), greater than Gossamer Bio, Inc. (6.74), greater than ERYTECH Pharma S.A. (3.65), greater than Aptorum Group Limited (1.18), greater than Unicycive Therapeutics, Inc. (3.61), greater than Armata Pharmaceuticals, Inc. (0.19), greater than CytomX Therapeutics, Inc. (1.04), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), greater than Spero Therapeutics, Inc. (2.68), greater than Assembly Biosciences, Inc. (2.36),

Build a custom stock screener for Surrozen, Inc. (SRZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surrozen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surrozen, Inc. (SRZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surrozen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.